Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer

Drug Discov Today. 2024 Jan 3:103875. doi: 10.1016/j.drudis.2023.103875. Online ahead of print.ABSTRACTN6-methyladenosine (m6A) is considered to be the most common and abundant epigenetics modification in messenger RNA (mRNA) and noncoding RNA. Abnormal modification of m6A is closely related to the occurrence, development, progression, and prognosis of cancer. m6A regulators have been identified as novel targets for anticancer drugs. Natural products, a rich source of traditional anticancer drugs, have been utilized for the development of m6A-targeting drugs. Here, we review the key role of m6A modification in cancer progression and explore the prospects and structural modification mechanisms of natural products as potential drugs targeting m6A modification for cancer treatment.PMID:38176674 | DOI:10.1016/j.drudis.2023.103875
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research